Elizabeth E Reed

Chief Legal Officer Elizabeth E Reed sells TVTX shares across three transactions while stock trades near 52-week highs amid unprofitable fundamentals.

Elizabeth E Reed, Chief Legal Officer of Travere Therapeutics, executed a mixed trading pattern over three days: acquiring approximately 24,250 shares through exercises while simultaneously divesting roughly 24,250 shares through three separate sales totaling over $1 million. The timing is notable — she is selling into strength, with the stock trading within a fraction of its 52-week high after a substantial rally over the prior month. Her historical record in this stock is exclusively sales (four prior trades, all dispositions), and the most recent sales in mid-April showed the stock subsequently appreciated, meaning those exits left money on the table — a pattern now repeating as she exits again near current highs. The company remains unprofitable with negative earnings, making this a case of an insider liquidating equity compensation near peak valuation rather than demonstrating confidence in fundamental improvement. The large sale volume warrants scrutiny to determine whether this reflects broader executive perspective on near-term prospects.

CLO Reed sells 51,500 shares for $2.1M at blended avg $41.29; retains 105.2K shares post-sale

Elizabeth E. Reed, Chief Legal Officer and General Counsel, executed 4 separate sales totaling 51,500 shares for $2,126,451.68 on April 14–15, 2026, at a blended average price of $41.29. The sale reduced her holdings by 32.9%, from 156,711 to 105,211 shares. Travere Therapeutics is profitable on a quarterly basis (net income $25.7M in latest quarter, revenue $164.9M with annual growth of +110.4%) but was unprofitable over the most recent full fiscal year; the stock currently trades at $40.95, near its 52-week high of $42.13, and has rallied 46.1% over the past 30 days. The magnitude and multi-tranche structure of the sale warrant attention, as does the timing relative to the stock's strong recent momentum and historical price levels.